These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1683836)

  • 1. Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men.
    Holmes D; Nuesch E; Houle JM; Rosenthaler J
    Eur J Clin Pharmacol; 1991; 41(2):175-8. PubMed ID: 1683836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics after a single oral dose of bopindolol in patients with cirrhosis.
    Wensing G; Branch RA; Humbert H; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1990; 39(6):569-72. PubMed ID: 1982762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Harron DW; Goa KL; Langtry HD
    Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
    Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
    Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The affinity of bopindolol and its two metabolites for a beta 2-adrenoceptor in the bovine mesenteric artery.
    Hosohata Y; Suzuki M; Karakisawa Y; Maruyama K; Nagatomo T
    Biol Pharm Bull; 1994 Sep; 17(9):1296-8. PubMed ID: 7841957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
    Grevel J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of renal impairment on the pharmacokinetics and metabolism of bopindolol.
    MacDonald NJ; Grant AC; Rodger RS; Meredith PA; Elliott HL
    Br J Clin Pharmacol; 1991 Jun; 31(6):697-700. PubMed ID: 1678272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging effects on the organic base transporter and stereoselective renal clearance.
    Ujhelyi MR; Bottorff MB; Schur M; Roll K; Zhang H; Stewart J; Markel ML
    Clin Pharmacol Ther; 1997 Aug; 62(2):117-28. PubMed ID: 9284847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Column liquid chromatographic determination of hydrolysed bopindolol, in the picogram per millilitre range in plasma, using cartridge extraction and dual electrochemical detection.
    Humbert H; Denouel J; Keller HP
    J Chromatogr; 1987 Nov; 422():205-15. PubMed ID: 2893803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of a new transdermal delivery system for bopindolol.
    Drewe J; Meier R; Timonen U; Thumshirn M; Munzer J; Kissel T; Gyr K
    Br J Clin Pharmacol; 1991 Jun; 31(6):671-6. PubMed ID: 1678271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age.
    Hulthén UL; van Brummelen P; Amann FW; Bühler FR
    J Cardiovasc Pharmacol; 1983; 5(3):426-9. PubMed ID: 6191141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
    Bagatin J; Kuzmanić A; Rumboldt Z; Mirić D; Naranca M; Obad M; Pivac N; Polić S; Rakić D
    Med Pregl; 1990; 43(3-4):145-8. PubMed ID: 1978233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effect of atenolol and bopindolol in the elderly.
    Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J
    Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
    Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
    Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
    J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselectivity in the steady-state pharmacokinetics and transplacental distribution of pindolol at delivery in pregnancy-induced hypertension.
    Gonçalves PV; Matthes Ado C; Da Cunha SP; Lanchote VL
    Chirality; 2002 Aug; 14(8):683-7. PubMed ID: 12125040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
    Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
    Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.